康臣药业3月26日举行董事局会议审阅及批准年度业绩

格隆汇2025-03-05

格隆汇3月5日丨康臣药业(01681.HK)此宣布，公司将于2025年3月26日(星期三)举行董事局会议，以处理以下事项：1.审阅及批准集团截至2024年12月31日止年度经审核综合财务报表("年度业绩")；2.审阅及批准将根据香港联合交易所有限公司证券上市规则公布的集团年度业绩公告草案；3.考虑派发末期股息(如有)；4.考虑召开公司应届股东周年大会的相关事宜；及5.考虑及批准其他事项(如有)。【...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2517995530?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-03-05 16:57","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2517995530","market":"hk","top_or_hot":-1,"title":"康臣药业3月26日举行董事局会议审阅及批准年度业绩","media":"格隆汇","content":"<div>\n<p>格隆汇3月5日丨康臣药业(01681.HK)此宣布，公司将于2025年3月26日(星期三)举行董事局会议，以处理以下事项：1.审阅及批准集团截至2024年12月31日止年度经审核综合财务报表(\"年度业绩\")；2.审阅及批准将根据香港联合交易所有限公司证券上市规则公布的集团年度业绩公告草案；3.考虑派发末期股息(如有)；4.考虑召开公司应届股东周年大会的相关事宜；及5.考虑及批准其他事项(如有)。【...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305170254989ce34d&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>康臣药业3月26日举行董事局会议审阅及批准年度业绩</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n康臣药业3月26日举行董事局会议审阅及批准年度业绩\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-03-05 16:57 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305170254989ce34d&s=b><strong>格隆汇</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>格隆汇3月5日丨康臣药业(01681.HK)此宣布，公司将于2025年3月26日(星期三)举行董事局会议，以处理以下事项：1.审阅及批准集团截至2024年12月31日止年度经审核综合财务报表(\"年度业绩\")；2.审阅及批准将根据香港联合交易所有限公司证券上市规则公布的集团年度业绩公告草案；3.考虑派发末期股息(如有)；4.考虑召开公司应届股东周年大会的相关事宜；及5.考虑及批准其他事项(如有)。【...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305170254989ce34d&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1191","symbol_name":"制药","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305170254989ce34d&s=b","article_id":"2517995530","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305170254989ce34d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2517995530","pubTimestamp":1741165022,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"格隆汇3月5日丨康臣药业此宣布，公司将于2025年3月26日(星期三)举行董事局会议，以处理以下事项：1.审阅及批准集团截至2024年12月31日止年度经审核综合财务报表；2.审阅及批准将根据香港联合交易所有限公司证券上市规则公布的集团年度业绩公告草案；3.考虑派发末期股息(如有)；4.考虑召开公司应届股东周年大会的相关事宜；及5.考虑及批准其他事项(如有)。请读者仅作参考，并请自行承担全部责任。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK1191":"制药","BK1606":"中医药概念","01681":"康臣药业"},"translate_title":"Consun Pharmaceutical held a board meeting on March 26 to review and approve the annual results","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"01681":1},"content_text":"格隆汇3月5日丨康臣药业(01681.HK)此宣布，公司将于2025年3月26日(星期三)举行董事局会议，以处理以下事项：1.审阅及批准集团截至2024年12月31日止年度经审核综合财务报表(\"年度业绩\")；2.审阅及批准将根据香港联合交易所有限公司证券上市规则公布的集团年度业绩公告草案；3.考虑派发末期股息(如有)；4.考虑召开公司应届股东周年大会的相关事宜；及5.考虑及批准其他事项(如有)。【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱：news_center@staff.hexun.com","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"conferences","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2517995530","isCrawlerRequest":true}